ZD 1611

Known as: ZD-1611, ZD1611 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2013
0119982013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
We evaluated immunohistochemistry (von Willebrand Factor [vWF] or fibrinogen) and systemic and coronary arterial physiological… (More)
Is this relevant?
2010
2010
Cerebral ischemia from middle cerebral artery wall (MCA) occlusion results in increased expression of cerebrovascular endothelin… (More)
Is this relevant?
2007
2007
Cerebral ischemia results in enhanced expression of smooth muscle cell endothelin and angiotensin receptors in cerebral arteries… (More)
Is this relevant?
2003
2003
Two endothelin antagonists, ZD1611 (3-[4-[3-(3-methoxy-5-methylpyrazin-2-ylsulfamoyl)-2-pyridyl]phenyl]-2,2-dimethylpropanoic… (More)
Is this relevant?
1999
1999
Endothelin-1 (ET-1) is a potent vasoconstrictor and comitogen implicated in the pathogenesis of pulmonary hypertension (PH). We… (More)
Is this relevant?
1999
1999
The endothelins (ETs), potent vasoconstrictor peptides, have been implicated in the pathogenesis of various cardiovascular… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?